Diagnosis of biphenotypic acute leukemia: A paradigmatic approach

International Journal of Clinical and Experimental Pathology

Volumn 3, Issue 1, 2010, Pages 75-86

  Zhao, Xianfeng Frank ^a,b   Gojo, Ivana ^a,b   York, Teresa ^a,b   Ning, Yi ^a   Baer, Maria R ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

ALL; AML; Biphenotypic acute leukemia; classification; EGIL

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

ACUTE BIPHENOTYPIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLASSIFICATION; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CHILD; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, BIPHENOTYPIC, ACUTE; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77449114378     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Weir EG, Ali Ansari-Lari M, Batista DA, Griffin CA, Fuller S, Smith BD, Borowitz MJ. Acute bilineal leukemia: a rare disease with poor outcome. Leukemia 2007; 21: 2264-2270.
2. Brunning RD, Head D, Matutes E, et al. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds): World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. p106-107.
3. Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayr H, McCulloch EA. Lineage infidelity in acute leukemia. Blood 1983; 61: 1138-1145.
4. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-1786.
5. Aribi A, Bueso-Ramos C, Estey E, Estrov Z, O'Brien S, Giles F, Faderl S, Thomas D, Kebriaei P, Garcia-Manero G, Pierce S, Cortes J, Kantarjian H, Ravandi F. Biphenotypic acute leukaemia: A case series. Br J Haematol 2007; 138: 213-216.
6. Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, Behm FG, Campana D, Razzouk BI, Ribeiro RC, Downing JR, Pui CH. Acute mixed lineage leukemia in children: The experience of St. Jude Children's Research Hospital. Blood 2009; 113: 5083-5089.
7. Borowitz MJ, Bene M-C, Harris NL, Porwit A, Matutes E. Acute leukemias of ambiguous lineage. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds.): WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. IARC: Lyon 2008. p149-155.
8. Georgy M, Yonescu R, Griffin CA, Batista DA. Acute mixed lineage leukemia and a t(6;14)(q25;q32) in two adults. Cancer Genet Cytogenet 2008; 185: 28-31.
9. Acute biphenotypic leukemia, Genetic and Rare Diseases Information Center (GARD), NIH. Available from: http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&diseaseID=8638
10. Sakaguchi N, Kashiwamura, S, Kimoto M, Thalmann P, Melchers F. B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. EMBO J 1988; 7: 3457-3464.
11. Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, Bolen JB, Nussenzweig M. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med 1993; 178: 1049-1055.
12. Buccheri V, Mihaljević B, Matutes E, Dyer MJ, Mason DY, Catovsky D. mb-1: A new marker for B-lineage lymphoblastic leukemia. Blood 1993; 82: 853-857.
13. Kozlov I, Beason K, Yu C, Hughson M. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Cancer Genet Cytogenet 2005; 163: 62-67.
14. Cruse JM, Lewis RE, Pierce S, Lam J, Tadros Y. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias. Exp Mol Pathol 2005; 79: 39-41.
15. Lai R, Juco J, Lee SF, Nahirniak S, Etches WS. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias. Am J Clin Pathol 2000; 113: 823-830.
16. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992; 80: 470-477.
17. He G, Wu D, Sun A, Xue Y, Jin Z, Qiu H, Tang X, Miao M, Fu Z, Ma X, Wang X, Chen Z, Ruan C. B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22). Int J Hematol 2008; 87: 132-136.
18. Brinkman-Van der Linden ECM, Sjoberg ER, Juneja LR, Crocker PR, Varki N, Varki A. Loss of N-glycolylneuraminic acid in human evolution: Implications for sialic acid recognition by siglecs. J Biol Chem 2000; 275: 8633-8640.
19. Janossy G, Coustan-Smith E, Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 1989; 3: 170-181.
20. Paredes-Aguilera R, Romero-Guzman L, Lopez-Santiago N, Burbano-Ceron L, Camacho-Del Monte O, Nieto-Martinez S. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol 2001; 68: 69-74.
21. Toba K, Hanawa H, Fuse I, Sakaue M, Watanabe K, Uesugi Y, Higuchi W, Takahashi M, Aizawa Y. Difference in CD22 molecules in human B cells and basophils. Exp Hematol 2002; 30: 205-211.
22. Brown G, Hogg N, Greaves M. Candidate leukaemia-specific antigen in man. Nature 1975; 258: 454-456.
23. Braun MP, Martin PJ, Ledbetter JA, Hansen JA. Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood 1983; 61: 718-725.
24. Ritz J, Nadler LM, Bhan AK, Notis-McConarty J, Pesando JM, Schlossman SF. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood 1981; 58: 648-652.
25. Raife TJ, Lager DJ, Kemp JD, Dick FR. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia. Am J Clin Pathol 1994; 101: 296-299.
26. Abbas AK, Lichtman AH. Cellular and Molecular Immunology (5th Ed.): Saunders, Philadelphia, 2003.
27. Minguet S, Schamel WW. A permissive geometry model for TCR-CD3 activation. Trends Biochem Sci 2008; 33: 51-57.
28. Urbano-Ispizua A, Matutes E, Villamor N, Ribera JM, Feliu E, Montserrat E, Grañena A, Vives-Corrons JL, Rozman C. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. Br J Haematol 1990; 75: 202-207.
29. Inukai T, Saito M, Mori T, Nishino K, Abe T, Kinoshita A, Suzuki T, Kurosawa Y, Okazaki T, Sugita K, et al. Analysis of cytoplasmic and surface antigens in childhood T-cell acute lymphoblastic leukaemias: Clinical relevance of cytoplasmic TCR beta chain expression. Br J Haematol 1994; 87: 273-281.
30. Krenács L, Tiszalvicz L, Krenács T, Boumsell L. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol 1993; 171: 99-104.
31. Drexler HG, Thiel E, Ludwig WD. Acute myeloid leukemias expressing lymphoid-associated antigens: Diagnostic incidence and prognostic significance. Leukemia 1993; 7: 489-498.
32. Launder TM, Bray RA, Stempora L, Chenggis ML, Farhi DC. Lymphoid-associated antigen expression by acute myeloid leukemia. Am J Clin Pathol 1996; 106: 185-191.
33. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. The immunophenotype of adult acute myeloid leukemia: High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Am J Clin Pathol 1998; 109: 211-220.
34. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
35. Imamura N. Sensitive detection technique of myeloperoxidase precursor protein by flow cytometry with monoclonal antibodies. Am J Hematol 1998; 58: 241-243.
36. Hewson JW, Bradstock KF, Kerr A, Rose RG. Characterizing "difficult" acute leukemias. A combined electron microscopic and immunological marker study. Pathology 1986; 18: 99-110.
37. Hu ZB, Ma W, Uphoff CC, Metge K, Gignac SM, Drexler HG. Myeloperoxidase: Expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood 1993; 82: 1599-1607.
38. Conlin PA, Orden MB, Hough TR, Morgan DL. Myeloperoxidase-positive intravascular large B-cell lymphoma. Arch Pathol Lab Med 2001; 125: 948-950.
39. Nakase K, Sartor M, Bradstock K. Detection of myeloperoxidase by flow cytometry in acute leukemia. Cytometry 1998; 34: 198-202.
40. Arber DA, Snyder DS, Fine M, Dagis A, Niland J, Slovak ML. Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. Am J Clin Pathol 2001; 116: 25-33.
41. Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S. Mixed-lineage leukemia revisited: Acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood 1990; 76: 808-813.
42. Nakase K, Kita K, Shiku H, Tanaka I, Nasu K, Dohy H, Kyo T, Tsutani H, Kamada N. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms. Am J Clin Pathol 1996; 105: 761-768.
43. Baruchel A, Cayuela JM, Ballerini P, Landman-Parker J, Cezard V, Firat H, Haddad E, Auclerc MF, Valensi F, Cayre YE, Macintyre EA, Sigaux F. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts. Br J Haematol 1997; 99: 101-106.
44. Abdelhaleem M. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia. Exp Mol Pathol 2007; 83: 138-141.
45. Godfrey DI, Zlotnik A, Suda T. Phenotypic and functional characterization of c-kit expression during intrathymic T-cell development. J Immunol 1992; 149: 2281-2285.
46. Suggs JL, Cruse JM, Lewis RE. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias. Exp Mol Pathol 2007; 83: 471-473.
47. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders. Hum Pathol 1998; 29: 498-504.
48. Lee JH, Min YH, Chung CW, Kim BK, Yoon HJ, Jo DY, Shin HJ, Bang SM, Won JH, Zang DY, Kim HJ, Chi HS, Lee KH, Cheong JW, Kim JS, Kim SH, Park S, Park SY, Chung JS, Lee JH, Park CJ; Korean Society of Hematology AML/MDS Working Party. Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leuk Lymphoma 2008; 49: 700-709.
49. Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, Ramond S, Viguié F, Marie JP, Zittoun R. Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 1998; 100: 147-155.
50. Killick S, Matutes E, Powles RL, Hamblin M, Swansbury J, Treleaven JG, Zomas A, Atra A, Catovsky D. Outcome of biphenotypic acute leukemia. Haematologica 1999; 84: 699-706.
51. Rubio MT, Dhedin N, Boucheix C, Bourhis JH, Reman O, Boiron JM, Gallo JH, Lhéritier V, Thomas X, Fière D, Vernant JP. Adult T-biphenotypic acute leukaemia: Clinical and biological features and outcome. Br J Haematol 2003; 123: 842-849.
52. Lee MY, Tan TD, Feng AC. Clinicopathologic analysis of acute myeloid leukemia in a single institution: Biphenotypic acute myeloid leukemia may not be an aggressive subtype. J Chin Med Assoc 2007; 70: 269-273.
53. Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 2004; 101: 2788-2801.
54. Tiacci E, Pileri S, Orleth A, Pacini R, Tabarrini A, Frenguelli F, Liso A, Diverio D, Lo-Coco F, Falini B. PAX5 expression in acute leukemias: Higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res 2004; 64: 7399-7404.
55. Anderson K, Rusterholz C, Månsson R, Jensen CT, Bacos K, Zandi S, Sasaki Y, Nerlov C, Sigvardsson M, Jacobsen SE. Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes. Blood 2007; 109: 3697-3705.